Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical Use of RESTYLANE.

J S Dover1, A Carruthers, J Carruthers

  • 1SkinCare Physicians of Chestnut Hill, Chestnut Hill, MA, USA.

Skin Therapy Letter
|March 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal associations between individual changes in hormones, training motivation and physical performance in elite and non-elite trained men.

Biology of sport·2016
Same author

Translation of tobacco control programs in schools: findings from a rapid review of systematic reviews of implementation and dissemination interventions.

Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals·2014
Same author

Common problems in pediatric ophthalmology.

Canadian family physician Medecin de famille canadien·2011
Same author

The hydrolysis of the alkenyl group from enthanolamine-plasmalogen by oligodendroglial cell-enriched fractions.

Neurochemistry international·2010
Same author

Photoporation and cell transfection using a violet diode laser.

Optics express·2009
Same author

Botulinum toxin products overview.

Skin therapy letter·2008
Same journal

Exosomes in Dermatology.

Skin therapy letter·2026
Same journal

Zasocitinib: New Frontier in Tyrosine Kinase 2 Inhibition.

Skin therapy letter·2026
Same journal

Erratum to: Deuruxolitinib for Alopecia Areata.

Skin therapy letter·2026
Same journal

Advances in the Management of Hyperhidrosis.

Skin therapy letter·2026
Same journal

Topical Ruxolitinib for the Treatment of Hidradenitis Suppurativa.

Skin therapy letter·2026
Same journal

Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis.

Skin therapy letter·2026
See all related articles

Restylane, a non-animal stabilized hyaluronic acid (NASHA) filler, is a versatile option for augmentation. Clinical experience over 8 years shows NASHA is close to an ideal dermal filler for many applications.

Area of Science:

  • Dermatology
  • Aesthetic Medicine
  • Biomaterials

Background:

  • Dermal fillers are widely used for aesthetic and reconstructive purposes.
  • The ideal filler possesses specific characteristics including biocompatibility, longevity, and ease of use.
  • No single filler meets all clinical demands, necessitating versatile options.

Purpose of the Study:

  • To review the background and clinical applications of Restylane.
  • To evaluate Restylane as a versatile augmenting agent in aesthetic medicine.

Main Methods:

  • Literature review of Restylane's clinical use.
  • Analysis of 8 years of clinical experience with Restylane.

Main Results:

  • Restylane, a non-animal stabilized hyaluronic acid (NASHA), demonstrates significant versatility.

Related Experiment Videos

  • Clinical data over 8 years indicates NASHA is a highly effective and well-tolerated dermal filler.
  • Restylane addresses many requirements for an ideal augmenting agent.

    • Conclusions:

    • Restylane (NASHA) is a valuable and versatile option in the field of dermal fillers.
    • The extensive clinical use of Restylane supports its efficacy and safety profile.
    • Further research may continue to refine the applications of hyaluronic acid-based fillers.